Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$1.63B
Total Bought:
$103.10M
Total Sold:
$74.93M
Net Transaction:
+$28.17M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)1,961,7951,961,7950$367.40M$402.68M24.64%+$35.27M
Liquidia Corporation(LQDA)8,118,8928,118,8920$647.32M$245.68M15.03%-$401.64M
ABIVAX Société AnonymeADS(ABVX)1,557,9241,557,9240$207.61M$154.27M9.44%-$53.34M
Vaxcyte, Inc.(PCVX)2,188,6362,188,6360$127.23M$124.53M7.62%-$2.69M
Exelixis, Inc.(EXEL)1,553,2621,553,2620$84.51M$90.73M5.55%+$6.21M
Tango Therapeutics, Inc.(TNGX)2,500,1032,501,246+1,143$78.15M$62.41M3.82%-$15.75M
Adma Biologics Inc5,725,0075,875,007+150,000$47.92M$58.93M3.61%+$11.01M
Immunocore Holdings plcADS(IMCR)1,381,3171,672,141+290,824$43.86M$50.65M3.10%+$6.79M
Avalo Therapeutics, Inc.(AVTX)3,163,8663,268,303+104,437$58.47M$50.10M3.07%-$8.37M
LB Pharmaceuticals Inc(LBRX)1,438,0701,509,621+71,551$46.67M$49.62M3.04%+$2.95M
Viridian Therapeutics, Inc.(VRDN)2,193,9812,193,9810$40.30M$45.17M2.76%+$4.87M
Vor Biopharma Inc.(VOR)1,925,0661,925,0660$35.44M$36.73M2.25%+$1.29M
Inventiva S.A.ADS(IVA)8,163,1919,185,935+1,022,744$30.86M$33.90M2.07%+$3.04M
Opus Genetics, Inc.(IRD)6,077,0845,960,972-116,112$24.98M$28.85M1.77%+$3.87M
Aura Biosciences, Inc.(AURA)4,298,2484,590,253+292,005$30.52M$28.83M1.76%-$1.69M
Anika Therapeutics Inc1,435,1301,435,1300$21.00M$28.21M1.73%+$7.22M
SAB Biotherapeutics, Inc.(SABS)7,967,2078,736,898+769,691$31.07M$27.70M1.69%-$3.38M
Sagimet Biosciences Inc.COM SER A(SGMT)2,500,0002,794,484+294,484$19.32M$27.61M1.69%+$8.28M
Faeth Therapeutics, Inc.(FTH)629,467890,210+260,743$15.74M$26.47M1.62%+$10.74M
Tyra Biosciences, Inc.(TYRA)806,986910,749+103,763$25.78M$19.92M1.22%-$5.86M
Obsidian Therapeutics Inc0886,281+886,281$0$12.17M0.74%+$12.17M
Eupraxia Pharmaceuticals Inc.(EPRX)01,163,010+1,163,010$0$10.58M0.65%+$10.58M
Artiva Biotherapeutics, Inc.(ARTV)1,736,1111,481,043-255,068$16.84M$10.55M0.65%-$6.30M
Verrica Pharmaceuticals Inc.(VRCA)923,910923,9100$5.65M$4.43M0.27%-$1.22M
Tcgx Acquisition CorpCL A0200,000+200,000$0$2.50M0.15%+$2.50M
Cellectar Biosciences, Inc.(CLRB)469,998469,9980$1.31M$864.8K0.05%-$441.8K
MBX Biosciences, Inc.(MBX)200,0000-200,000$11.04M$0—-$11.04M
Xenon Pharmaceuticals Inc.(XENE)889,9440-889,944$53.72M$0—-$53.72M
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q3 2026 | TickerTrail